Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
7.52
-0.06 (-0.79%)
At close: Mar 3, 2026, 4:00 PM EST
7.54
+0.02 (0.27%)
After-hours: Mar 3, 2026, 7:39 PM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $19.05 million as of March 3, 2026. Its market cap has decreased by -41.87% in one year.
Market Cap
19.05M
Enterprise Value
12.11M
1-Year Change
-41.87%
Ranking
Category
Stock Price
$7.52
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $19.05M, a decrease of -71.13%. That is a compound annual growth rate of -37.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 19.21M | -22.05% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 22.37M |
| FibroBiologics | 22.21M |
| Polyrizon | 20.72M |
| Pasithea Therapeutics | 20.36M |
| VYNE Therapeutics | 19.99M |
| Cadrenal Therapeutics | 19.85M |
| Serina Therapeutics | 19.41M |
| BioAtla | 18.37M |